Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Janssen Biotech, Inc.
483
•Janssen Biotech, Inc.•March 5, 2018

Janssen Biotech, Inc. – FDA 483, Mar 5, 2018

Record Details

An FDA inspection of Janssen Biotech, Inc.'s Malvern, PA facility, conducted from February 21 to March 5, 2018, revealed significant issues in their quality control and investigation procedures. The Food and Drug Administration observed that written records of investigations into batch failures and out-of-specification components were incomplete. Specifically, several batches of Bovine APO Transferrin were released and utilized in API production, despite exceeding Ethylenediaminetetraacetic Acid (EDTA) action limits, without thorough lab event investigations. The media lots containing these non-compliant components were also not tested for EDTA. Additionally, an investigation into a decreased Process Capability for API Pre-formulated Bulk (PFB) Bioactivity Assay was deemed incomplete due to the absence of a review and assessment of stability data. These observations highlight the necessity for Janssen Biotech, Inc. to enhance their investigative processes for product and component deviations to ensure comprehensive root cause analysis and maintain consistent product quality and regulatory compliance. The company is expected to implement robust corrective actions to address these findings.

Company
Janssen Biotech, Inc.
Inspection date
March 5, 2018
Product type
biologics
Office
Philadelphia District Office
People
  • Christopher J. Ewer (General Manager of Operations)
  • Anita R. Michael (Investigator)
View Company Profile

ID · 7bb1eae4-93cc-4e04-a24d-a92ba5419340

Other documents for Janssen Biotech, Inc.
  • 483 - 2025-07-29July 29, 2025
  • EIR - 2018-11-30November 30, 2018
  • EIR - 2018-03-05March 5, 2018
  • 483 - 2017-05-18May 18, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Janssen Biotech, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.